logo
  

DepoMed Inc. (DEPO) Is Rising After Unexpected Q4 Profit

DepoMed Inc. (DEPO) reported fourth quarter EPS of $0.72 after the bell Wednesday, compared to the loss of $0.07 in the previous year. Analysts expected a loss of $0.20. Full year 2014 non-GAAP EPS is expected to be between break-even and $0.16. The consensus estimate is for a loss of $0.08. The stock is now up 1 point on 3K shares.

DepoMed gapped open higher Wednesday, but traded in a range for the majority of the session. The stock closed up by 0.49 at $13.50.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.

A busy week for economics saw the release of first quarter growth figures for the U.S. economy and the interest rate decision in Japan. Read our stories to find out why the GDP data damped market sentiment in the U.S. and what were the signals given out by the Bank of Japan. Other news this week included new home sales data and jobless claims figures from the U.S., and the latest purchasing managers' survey results for the Eurozone.

View More Videos
Follow RTT